Hayward, CA, United States of America

Balint Gal

USPTO Granted Patents = 6 

Average Co-Inventor Count = 16.5

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
6 patents (USPTO):

Title: Balint Gal: Innovator in Pharmaceutical Compounds

Introduction

Balint Gal is a prominent inventor based in Hayward, California, known for his significant contributions to the field of pharmaceuticals. With a total of six patents to his name, he has made strides in developing compounds that target critical pathways in various diseases.

Latest Patents

Among his latest patents, one notable invention is focused on compounds as inhibitors of AXL. These compounds, described as Formula I, are designed to inhibit AXL and include compositions for synthesizing these compounds. The applications of these compounds extend to treating a range of diseases, including cancer, that are mediated by AXL. Another significant patent involves a process for preparing tetralin compounds, detailing methods and intermediates useful for synthesizing these compounds at multigram or kilogram scales.

Career Highlights

Balint Gal has established himself as a key figure in the pharmaceutical industry, particularly through his work at Arcus Biosciences, Inc. His innovative approaches to drug development have positioned him as a valuable asset in the quest for effective treatments.

Collaborations

Throughout his career, Balint has collaborated with notable colleagues, including Joel Worley Beatty and Manmohan Reddy Leleti. These partnerships have fostered an environment of innovation and have contributed to the advancement of their shared goals in pharmaceutical research.

Conclusion

Balint Gal's work exemplifies the impact of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to developing effective treatments for complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…